| Ms Natalie Yolanda Stacchini, RNFA | |
|
102 N Evergreen Avenue, Longport, NJ 08403 | |
| (267) 884-3175 | |
| Not Available |
| Full Name | Ms Natalie Yolanda Stacchini |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Perioperative |
| Location | 102 N Evergreen Avenue, Longport, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699046151 | NPI | - | NPPES |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Natalie Yolanda Stacchini, RNFA 102 N Evergreen Avenue, Longport, NJ 08403-1414 Ph: (267) 884-3175 | Ms Natalie Yolanda Stacchini, RNFA 102 N Evergreen Avenue, Longport, NJ 08403 Ph: (267) 884-3175 |
News Archive
The Partnership for Quality Home Healthcare – a coalition of home health providers dedicated to improving the integrity, quality, and efficiency of home healthcare for our nation's seniors – today commended Senator Ron Wyden (D-OR), Senator Johnny Isakson (R-GA), Congressman Erik Paulsen (R-MN) and Congressman Peter Welch (D-VT) for introducing the Better Care, Lower Cost Act of 2014 (S.1932/H.R.3890) to improve the management of care for Medicare beneficiaries living with chronic conditions.
Endo Pharmaceuticals today reported financial results for the first quarter 2010.
A new study shows that nearly half of phase 3 cancer clinical trials carried out by the National Cancer Institute (NCI)-sponsored SWOG Cancer Research Network, one of five groups in NCI's National Clinical Trials Network (NCTN), were associated with clinical care guidelines or new drug approvals. NCI is part of the National Institutes of Health.
A UK study in this week's issue of THE LANCET highlights how surgery in addition to compression treatment could substantially reduce the risk of recurrent leg ulcers.
Experts at the Center for Tobacco Research and The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute are making a case for why the U.S. Food and Drug Administration's proposed rule to add 13 new graphic warnings for cigarette packages and advertisements should be allowed to go into effect.
› Verified 2 days ago